AzTrials
AzTrials

C23.888.592.612.081DEF IINCT05527600

Evaluation of an App Based on Artificial Intelligence for Pain Assessment in Pediatric Department

An observational study of C23.888.592.612.081, run by Centre Hospitalier Universitaire de Nice at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Accurate assessment of pain in Pediatric Department is challenging. However, recent publications highlight that children do not receive optimal pain management, particularly in Emergency Departments. An Artificial Intelligence-based tool could help physicians to optimize analgesia use. Read more about this study

Who is it for?
Ages 0 days to 18 years
Conditions the study is for
C23.888.592.612.081
What is being tested?
intensity of acute pain evaluation
How many people
2,500 participants
Where
2 sitesFrance
Study dates
7 Mar 2023to 12 Sep 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 days to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: 2000 patients under 18 year old admitted in Emergency Department

Who may be able to join

  • Child under 18
  • Informed and written consent of a parent or guardian (only 1 accompanying person allowed).

Who cannot join

  • Language barrier.
  • Refusal to participate by parents/children
  • Sign of collapsus, or in serious clinical condition (stage I or II) requiring absolute emergency care,
  • Delayed mental or staturo-ponderal development
  • Facial injury or wound, presence of a bandage on the face, pre-existing facial deformity

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • CHU de Nice

    Nice, CHU de NICE, 06003

  • Hopital pédiatrique Fondation Lenval

    Nice, 06000

Other trials in France

About this study

Official title: Development and Validation of a System Based on Digital Face Recognitation for Pain Assessment in Children's Emergency

Accurate assessment of pain in Pediatric Department is challenging. However, recent publications highlight that children do not receive optimal pain management, particularly in Emergency Departments.

An Artificial Intelligence-based tool could help physicians to optimize analgesia use.

Read the detailed description

Acute pain is the reason that the majority of patients present to the Emergency Department. Multiple studies conducted over many years have demonstrated that pain is poorly managed in the Emergency Department. This phenomenon has been referred to in the Medical Literature as "Oligoanalgesia.". Morever, untreated pain can have short and long term effects in Pediatric population, including sensitisation to pain episodes in later life and can affects the Neurodevelopment of the child.

The generally accepted standard for pain assessment is self-reported; however, in preverbal children who cannot communicate their pain, age-appropriate behavioural or observational pain assessment tools are recommended. Because children are not always able to voice their feelings, they completely depend on their caregiving team for the interpretation and management of their pain and discomfort. Thus, accurately validated scales to assess pain levels are crucial. In France, the EVENDOL is the most used widely scale. The EVENDOL scale (from the French Evaluation Enfant Douleur) is used to evaluate pain in children in any situation covering a wider age group than other pain scales (birth up to seven years). Despite a large number of scales with a variety of Psychometric properties having been published in the last decades, to date, there is no criterion standard when considering the assessment of pain. As a result, children continue to be suffered pain without adequate pain management. International guidelines incorporate the need for prompt recognition of pain.

Artificial Intelligence (AI) in Medicine is booming and has already proven its worth in terms of prevention, monitoring and diagnosis. AI in this field can be used to support clinician decision making, allow curiosity-driven care, remove the need to complete mundane tasks, improve communication, and facilitate collaboration. Evaluation of the face is central to all observational pain assessment tools, as the face is highly accessible and facial expressions are considered the most encodable feature of pain Therefore.the investigators aim to develop, validate and asses a system based on Digital Face Recognitation for pain assessment in the Children's Department.

Being tested
intensity of acute pain evaluation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • intensity of acute pain evaluationDiagnostic test

    the facial expression of each patient will be collected from a short video of 10 seconds, follow by with the evaluation of the pain intensity.

Study groups in NCT05527600
Study groupRoleWhat they receive
assessment of pain in Pediatric Department2000 children patients admitted in emmergency department
Receives: Diagnostic Test: intensity of acute pain evaluation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. assessment of The intensity of acute pain with the EVENDOL Scale

    The intensity of acute pain will be assessed by the current reference French methods for evaluating pain in children with the EVENDOL Scale (reference between 0 and 7 years).

    Measured: day 0

  2. assessment of The intensity of acute pain with the VAS Scale

    The intensity of acute pain will be assessed by the current reference French methods for evaluating pain in children with the VAS Scale (Age > 7 years)

    Measured: day 0

  3. the facial expression captured by short video

    a short 10-second video is collected to assess facial expression of pain in children

    Measured: day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2022
  2. Study start7 Mar 2023
  3. Primary completion7 Mar 2023
  4. Study completion12 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
2,500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05527600
Sponsor's protocol ID
21-PP-16
Other IDs
2021-A02726-35
Acronym
DEF II
Status last verified
Jan 2024
First submitted
30 Aug 2022
Last updated
12 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of C23.888.592.612.081, run by Centre Hospitalier Universitaire de Nice at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

assessment of The intensity of acute pain with the EVENDOL Scale (time frame: day 0). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in